Skip to main content
main-content

Onkologie und Hämatologie | Zeitschrift

memo - Magazine of European Medical Oncology

memo - Magazine of European Medical Oncology 2/2012

Ausgabe 2/2012

Inhaltsverzeichnis ( 21 Artikel )

01.06.2012 | editorial | Ausgabe 2/2012

Cellular immunotherapy for cancer. Past, present, future

Alexandros Spyridonidis MD, PhD

01.06.2012 | editorial | Ausgabe 2/2012

Breast cancer—advanced stage: “cure—still a long way to go?”

Herbert Stöger MD

01.06.2012 | editorial | Ausgabe 2/2012

Clinical practice guidelines in oncology—achievements and challenges

Günther Gastl MD

01.06.2012 | short review | Ausgabe 2/2012

Immunotherapy for nonsmall-cell lung cancer

Astrid Belalcazar MD, Luis E. Raez MD, FACP, FCCP, MACSG, Edgardo S. Santos MD, FACP

01.06.2012 | short review | Ausgabe 2/2012

Immunotherapeutic approaches targeting prostate cancer and its microenvironment

Robert Zeiser MD

01.06.2012 | short review | Ausgabe 2/2012

Natural killer cell based immunotherapy for eradication of minimal residual disease in patients with malignant disorders

Panagiotis D. Tsirigotis M.D., Nikolaos Papanikolaou M.D.

01.06.2012 | short review | Ausgabe 2/2012

The role of biomarkers in the choice of therapy in breast cancer

Brigitte Mlineritsch MD, Sigrun Ressler MD, Prof. Richard Greil MD

01.06.2012 | review | Ausgabe 2/2012

Evolving strategies to overcome endocrine resistance in breast cancer

Michael Hubalek M.D., Christine Brunner M.D., Christian Marth M.D.

01.06.2012 | review | Ausgabe 2/2012

What’s new in metastatic breast cancer?

Rupert Bartsch MD

01.06.2012 | short review | Ausgabe 2/2012

Surgical removal of the primary?—The role it plays in stage IV breast cancer

Florian Fitzal MD, FEBS

01.06.2012 | short review | Ausgabe 2/2012

The role of Positron Emission Tomography/Computer Tomography (PET/CT) in the diagnosis, staging, characterization, and therapy of breast cancer

Zoltán Lőcsei MD, Katalin Hideghéty MD, PhD, Dr. habil. Zsuzsanna Kahán MD, PhD

01.06.2012 | short review | Ausgabe 2/2012

Breast cancer: is there a need for biopsy of metastases?

Flora Zagouri MD, PhD, Martin Filipits PhD

01.06.2012 | short review | Ausgabe 2/2012

Advanced breast cancer: new imaging techniques for detection of metastases

Helmut Schoellnast MD, Christian Gstettner MD

01.06.2012 | original report | Ausgabe 2/2012

Treatment outcome in AML: a single-centre experience in an unselected patient cohort

Kathrin Strasser-Weippl MD, Martin Schreder MD, Niklas Zojer MD, PhD, Heinz Ludwig MD, PhD

01.06.2012 | case report | Ausgabe 2/2012

Sjögren syndrome complicated with hairy-cell leukemia: a case-based review

Noushin Bayat, Hasan Bagheri, Reza Karbasi-Afshar, Alireza Saadat, Farhad Sarrafzadeh, Amin Saburi

01.06.2012 | short review | Ausgabe 2/2012

Lung cancer screening: current evidence and recommendations

Michael Mark MD, Martin Brutsche MD, PhD, Oliver Gautschi MD

01.06.2012 | review | Ausgabe 2/2012

Interventional therapy for symptomatic bronchial carcinoma

Christian Geltner M.D.

01.06.2012 | case report | Ausgabe 2/2012

Is distinct EGFR mutation status proof of second simultaneous primary non-small cell lung cancer?

Ulf Petrausch, Verena Tischler, Walter Weder, Rolf Stahel, Alex Soltermann

01.06.2012 | short review | Ausgabe 2/2012

Recent advances and future challenges in the treatment of upper gastrointestinal malignancies

Dieter Koeberle MD, Anna Dorothea Wagner MD

01.06.2012 | comment | Ausgabe 2/2012

Advances in haematology and oncology 2011: hepatocellular carcinoma (HCC)

Markus Peck-Radosavljevic MD

01.06.2012 | short review | Ausgabe 2/2012

Highlights in the adjuvant treatment of colon cancer from annual meetings 2011

Gudrun Resch MSc, MD, Prof. Josef Thaler MD

Aktuelle Ausgaben